June 21, 2021
Learn More
![](https://www.insight-rx.com/wp-content/uploads/2022/05/Biomarker-Guided-and-Pharmacogenomic-Informed-Dosing.jpeg)
April 05, 2022
Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
On our Year in Review webinar, presenters Stephanie Hughes, PharmD, BCIDP, Clinical Applications Specialist, and Jon Faldasz, PharmD, BCPS, our Senior Director of Product & Customer Experience, shared a sneak peek at an exciting expansion on the horizon. In 2022, InsightRX will extend the InsightRX Nova platform beyond therapeutic drug monitoring (TDM) into two other categories: biomarker-guided dosing and pharmacogenomic-informed dosing.
Read Full Article
Filter By:
Apply Filters
Category
![Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing](https://www.insight-rx.com/wp-content/uploads/2022/05/Biomarker-Guided-and-Pharmacogenomic-Informed-Dosing-1024x614.jpeg)
April 05, 2022
Learn More
Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
![Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas](https://www.insight-rx.com/wp-content/uploads/2022/05/InsightRX-BlogImage-3-min-p-3200-1024x683.jpeg)
March 24, 2022
Learn More
Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas
![Recent Product Enhancements](https://www.insight-rx.com/wp-content/uploads/2022/05/Recent-Product-Enhancements_InsightRX-1024x683.jpeg)
March 10, 2022
Learn More